SERIES X-1 COMMON STOCK PURCHASE WARRANT PAVMED inc.Warrant Agreement • December 21st, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • Delaware
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the later of (i) the date the final stockholder approval has been obtained under Nasdaq Stock Market Rule 5635(d) or a successor rule allowing for the issuance of certain of the Securities being issued under the Purchase Agreement (as defined below) and (ii) October 31, 2018 (the “Initial Exercise Date”) and on or prior to the close of business on April 30, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PAVmed Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warra
AMENDMENT AGREEMENTAmendment Agreement • December 21st, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • Delaware
This Amendment Agreement (this “Agreement”) is made and entered into as of October 18, 2017, by and among PAVmed, Inc., a Delaware corporation (the “Company”), and each of the holders of (i) shares of the Company’s Series A-1 Preferred Stock and (ii) Series A-1 Warrants (as such terms are defined below) who are identified on the signature page of this Agreement as a “Holder” (each, a “Holder” and collectively, the “Holders”). The Company and the Holders are sometimes referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
